The Ultran Group, Inc.

The Ultran Group, Inc. is a small business manufacturer headquartered in State College, Pennsylvania, specializing in the design and development of advanced ultrasonic transducers and systems for federal government applications. Since its registration to receive federal awards in December 2001, the company has established itself as a specialized provider of non-contact and low-frequency ultrasonic technology solutions across multiple defense and medical research initiatives. The Ultran Group operates as a for-profit corporate entity and has demonstrated sustained expertise in leveraging ultrasonic principles for both therapeutic and diagnostic applications within the defense and medical device sectors.

The Ultran Group's federal contract portfolio reflects a diversified engagement across multiple defense and research agencies, with a particular emphasis on Small Business Innovation Research (SBIR) programs. Most recently, the Air Force Research Laboratory awarded the company a $139,926 firm fixed price contract under the SBIR Phase I program in September 2025, focused on developing and validating ultrasonic inspection techniques capable of detecting bonded composite structure defects through fairing materials for aircraft maintenance applications. Prior to this, the Defense Advanced Research Projects Agency (DARPA) awarded a significant $2,999,629 SBIR Phase II contract in February 2024 for the development of a wearable ultrasonic device designed for patient self-administered treatment of inflammation, with performance scheduled through August 2025. The company's engagement with DARPA extends further back to 2019, when it received a Phase II contract valued at over $6.1 million

for wearable ultrasound imaging and modulation capabilities. Additionally, The Ultran Group received a subcontract award in June 2023 related to ultrasonic transducer provision. All identified prime contract awards have carried total small business set-aside designations, reflecting the company's status as a qualified small business contractor. These contracts demonstrate the company's core competency in advanced ultrasonic technology development spanning medical therapeutic devices, diagnostic inspection systems, and imaging applications for both defense and dual-use purposes.

The Ultran Group, Inc. holds an Other Transaction Indefinite Delivery Vehicle (IDV) awarded by the Joint Program Executive Office for Chemical and Biological Defense (JPEOs-CBD), a component of the Department of Defense, established on September 20, 2021, with a ceiling value of $3.3 million. This IDV was awarded without set-aside provisions and establishes a mechanism through which the company provides research and development services in support of the JPEOs-CBD's chemical and biological defense mission. The contract scope encompasses technical and analytical services, with documented emphasis on emerging health-related research applications, including a noted focus on "Long COVID effort" continuation work as indicated in the statement of work revisions. As an indefinite delivery vehicle structure, the IDV enables the government to issue task orders up to the $3.3 million ceiling as requirements are identified and refined, providing the JPEOs-CBD flexible access to The Ultran Group's specialized ultrasound-based research and development capabilities aligned with chemical and biological defense objectives. The company's demonstrated expertise in wearable ultrasound technology development and its track record with DARPA positions it to deliver advanced technical solutions under this IDV framework for defense-related health and medical research initiatives.

Manufacturer of Ultrasonic Transducers and related Non-destructive analysis systems for industrial, laboratory and medical research applications.